FIELDS RANDALL K 4

What Happened
Randall K. Fields, CEO of ReposiTrak, sold a total of 7,500 shares of TRAK in two open-market transactions: 2,200 shares on 2026-02-24 (weighted avg price reported $8.50, proceeds $18,706) and 5,300 shares on 2026-02-25 (weighted avg price reported $8.34, proceeds $44,186). Total reported proceeds across both sales were $62,892. These were sales (not purchases), which are often routine dispositions rather than a directional endorsement of the stock.

Key Details

• Transaction dates and reported amounts:
  • 2026-02-24: 2,200 shares, weighted avg price $8.50, proceeds $18,706. (Footnote F2: sales executed in multiple trades at prices ranging $8.385–$8.58.)
  • 2026-02-25: 5,300 shares, weighted avg price $8.34, proceeds $44,186. (Footnote F3: sales executed in multiple trades at prices ranging $8.15–$8.52.)
• Total shares sold: 7,500; total reported proceeds: $62,892.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Notable footnote (F1): The sales occurred pursuant to a pre-established Rule 10b5-1 trading plan, adopted by Fields in his capacity as Trustee of a charitable remainder unitrust to meet charitable commitments.
• Filing/timeliness: Form filed 2026-02-26. No late-filing flag was provided in the information you supplied.

Context
Sales executed under a Rule 10b5-1 plan are pre-arranged and scheduled in advance; they are commonly used to satisfy financial or charitable obligations and do not necessarily indicate new insider views on the company’s prospects. For retail investors, purchases by insiders typically carry more emphasis as potential bullish signals; routine sales—especially under a 10b5-1 plan—are common and often administrative.